Capricor Therapeutics Inc (CAPR)
5.495
+0.26
(+4.87%)
USD |
NASDAQ |
May 03, 14:40
Capricor Therapeutics 1 Year Total Returns (Daily): 39.36% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 02, 2024 | 39.36% |
| May 01, 2024 | 36.32% |
| April 30, 2024 | 35.48% |
| April 29, 2024 | 37.02% |
| April 26, 2024 | 36.96% |
| April 25, 2024 | 31.04% |
| April 24, 2024 | 23.83% |
| April 23, 2024 | 16.99% |
| April 22, 2024 | 19.90% |
| April 19, 2024 | 18.44% |
| April 18, 2024 | 19.67% |
| April 17, 2024 | 29.37% |
| April 16, 2024 | 35.39% |
| April 15, 2024 | 33.79% |
| April 12, 2024 | 47.41% |
| April 11, 2024 | 45.22% |
| April 10, 2024 | 48.58% |
| April 09, 2024 | 57.89% |
| April 08, 2024 | 57.42% |
| April 05, 2024 | 60.38% |
| April 04, 2024 | 60.67% |
| April 03, 2024 | 61.52% |
| April 02, 2024 | 63.27% |
| April 01, 2024 | 68.13% |
| March 28, 2024 | 65.61% |
| Date | Value |
|---|---|
| March 27, 2024 | 64.72% |
| March 26, 2024 | 53.16% |
| March 25, 2024 | 60.92% |
| March 22, 2024 | 49.07% |
| March 21, 2024 | 56.36% |
| March 20, 2024 | 52.90% |
| March 19, 2024 | 56.45% |
| March 18, 2024 | 55.76% |
| March 15, 2024 | 42.95% |
| March 14, 2024 | 32.97% |
| March 13, 2024 | 31.13% |
| March 12, 2024 | 27.16% |
| March 11, 2024 | 25.00% |
| March 08, 2024 | 24.66% |
| March 07, 2024 | 5.88% |
| March 06, 2024 | 7.35% |
| March 05, 2024 | 2.16% |
| March 04, 2024 | -3.71% |
| March 01, 2024 | -9.24% |
| February 29, 2024 | -7.69% |
| February 28, 2024 | -4.84% |
| February 27, 2024 | -3.77% |
| February 26, 2024 | -11.01% |
| February 23, 2024 | -12.33% |
| February 22, 2024 | -9.77% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-84.22%
Minimum
Apr 02 2020
478.7%
Maximum
Mar 10 2021
16.52%
Average
-2.97%
Median
Sep 25 2023
1 Year Total Returns (Daily) Benchmarks
| Cutera Inc | -87.68% |
| Sarepta Therapeutics Inc | 5.57% |
| PTC Therapeutics Inc | -38.84% |
| Solid Biosciences Inc | 95.61% |
| AIM ImmunoTech Inc | -16.66% |